Proteinuria

7 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Albuminuria 3

Treatments and conditions

Proteinuria
Treatment and conditionWhere it standsTrials
ARBs in combination of SGLT2i for proteinuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atrasentan for proteinuriaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Iptacopan for proteinuriaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
JADE101 for proteinuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for albuminuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + SOTAGLIFLOZIN for albuminuriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for albuminuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.